BrightSpring Health Services Inc (NASDAQ:BTSG) does about 1.45M shares in volume on a normal day but saw 268075 shares change hands in the recent trading day. The company now has a market cap of 3.04B USD. Its current market price is $17.44, marking an increase of 0.23% compared to the previous close of $17.40. The 52 week high reached by this stock is $20.25 whilst the lowest price level in 52 weeks is $7.85.
BrightSpring Health Services Inc (BTSG) has a 20-day trading average at $18.27 and the current price is -13.88% off the 52-week high compared with 122.17% distance from its 52-week low. The 50-day simple moving average of the closing price is $17.77 and its 200-day simple moving average is $13.24. If we look at the stock’s price movements over the week, volatility stands at 5.13%, which decreases to 4.28% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 50.08 to suggest the stock is neutral.
The consensus objective for the share price is $22.17, suggesting that the stock has a potential upside of 21.34% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
BTIG Research initiated its price target at $15.
The current price level is -4.70%, -1.93%, and 31.65% away from its SMA20, SMA50, and SMA200 respectively, with the BTSG price moving above the 50-day SMA on current market day. BrightSpring Health Services Inc (BTSG) stock is down -2.28% over the week and -3.79% over the past month. Its price is 64.00% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at 0.2 and 0.56 for whole year. Expected sales for next quarter are $2.86B, which analysts say will come at $11.17B for the current fiscal year and next year at $12.39B. In addition, estimates put the company’s current quarterly revenue at an average of $2.96B.
To reach the target analysts have set, the stock logically needs to grow 21.34 percent from here.
The company has a return on investment of -0.91% and return on equity of -3.61%. The forward price to earnings ratio is 23.07. Price to book ratio is 1.88 and price to sales ratio is 0.29.
